Vietnam's magnetic resonance imaging (MRI) market is entering a new phase of growth as hospitals and diagnostic centres invest in advanced imaging technologies to meet rising demand for early disease detection, precision diagnostics and specialist healthcare services.
According to TechS i Research, Vietnam's MRI market was valued at US$234.7 million in 2025 and is projected to reach US$404.7 million by 2031. Growth is being driven by increasing healthcare expenditure, expanding hospital infrastructure and the rising prevalence of chronic diseases requiring advanced diagnostic imaging.
The market forms part of Vietnam's broader medical imaging sector, which reached US$232.8 million in 2025 and is forecast to grow to US$353.3 million by 2034, reflecting continued investment in diagnostic technologies across both the public and private healthcare sectors.
Several factors are accelerating demand for MRI systems across Vietnam:
Rising incidence of cancer, neurological disorders, cardiovascular disease and musculoskeletal conditions.
Government investment in upgrading public hospitals and expanding access to advanced diagnostic imaging.
Rapid growth of private hospitals and specialist diagnostic imaging centres.
Increasing emphasis on early diagnosis and preventative healthcare.
Adoption of artificial intelligence (AI)-enabled MRI systems to improve image quality, reduce scan times and enhance workflow efficiency.
Growing demand for high-performance 1.5T and 3T MRI systems across tertiary healthcare facilities.
Innovation is also reshaping Vietnam's imaging landscape. In 2025, Bayer and Siemens Healthineers introduced next-generation technologies including the MAGNETOM Flow, an AI-powered, helium-independent MRI scanner, alongside advanced CT imaging solutions. These systems are designed to improve diagnostic accuracy, reduce environmental impact and increase operational efficiency for healthcare providers.
Globally, MRI remains one of the fastest-growing segments of the medical imaging industry. Grand View Research estimates that MRI accounted for the largest share of the global medical imaging market by technology in 2025, with continued growth being driven by technological innovation, increasing demand for non-invasive diagnostics and expanding applications across oncology, neurology, cardiology and orthopaedics.
Leading manufacturers including Siemens Healthineers, GE HealthCare, Philips Healthcare, Canon Medical Systems and Fujifilm Healthcare continue to expand their presence across Southeast Asia, introducing AI-powered imaging platforms, faster acquisition technologies and more sustainable MRI systems to support the region's growing healthcare needs.
As Vietnam continues to modernise its healthcare infrastructure and expand access to advanced diagnostic services, MRI technology is expected to play an increasingly important role in improving clinical outcomes and supporting earlier disease detection. For manufacturers of imaging equipment, AI-enabled diagnostic software and radiology solutions, Vietnam represents one of Southeast Asia's most attractive growth markets.